{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:34:05Z","timestamp":1761237245555},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"vor","delay-in-days":1185,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>A disturbance in body water homeostasis is a common feature in advanced cirrhosis. This disturbance is always associated with the existence of ascites and is characterized by an inability to adjust the amount of water excreted in the urine to the amount of water ingested. Vasopressin (AVP) is of major importance in the pathogenesis of water retention and hyponatremia in cirrhosis.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The current study assessed the renal, hormonal and hemodynamic effects induced by 10\u2010day chronic oral administration of RWJ\u2010351647 (0.5\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup> daily), a new nonpeptide V<jats:sub>2<\/jats:sub>\u2010AVP antagonist, in rats with CCl<jats:sub>4<\/jats:sub>\u2010induced cirrhosis, ascites and severe water retention. Urine volume (UV), urine osmolality and sodium and potassium excretion were measured daily. At the end of the study, systemic hemodynamic parameters were also assessed.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Long\u2010term administration of RWJ\u2010351647 has an aquaretic effect in rats with cirrhosis, ascites, water retention and hypo\u2010osmolality. It increases UV (ANOVA: <jats:italic>F<\/jats:italic>=7.32, <jats:italic>P<\/jats:italic>&lt;0.0001) and reduces urine osmolality (ANOVA: <jats:italic>F<\/jats:italic>=12.69, <jats:italic>P<\/jats:italic>&lt;0.0001) throughout the entire period of treatment, thereby leading to a greater renal ability to excrete a water load at the end of the 10\u2010day treatment period (the percentage of water load excreted improved from 30\u00b18 to 92\u00b121%, <jats:italic>P<\/jats:italic>&lt;0.025).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The nonpeptide AVP V<jats:sub>2<\/jats:sub>\u2010receptor antagonist RWJ\u2010351647 also increased sodium excretion without affecting creatinine clearance and blood pressure.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>These data suggest that RWJ\u2010351647 could be therapeutically useful in the treatment of water retention in human cirrhosis.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p><jats:p><jats:italic>British Journal of Pharmacology<\/jats:italic> (2005) <jats:bold>146<\/jats:bold>, 654\u2013661. doi:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1038\/sj.bjp.0706375\">10.1038\/sj.bjp.0706375<\/jats:ext-link><\/jats:p>","DOI":"10.1038\/sj.bjp.0706375","type":"journal-article","created":{"date-parts":[[2005,8,22]],"date-time":"2005-08-22T09:24:11Z","timestamp":1124702651000},"page":"654-661","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sustained aquaretic effect of the V<sub>2<\/sub>\u2010AVP receptor antagonist, RWJ\u2010351647, in cirrhotic rats with ascites and water retention"],"prefix":"10.1111","volume":"146","author":[{"given":"Josefa","family":"Ros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Fern\u00e1ndez\u2010Varo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Mu\u00f1oz\u2010Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Rod\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W","family":"Gunnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith T","family":"Demarest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980179c"},{"key":"e_1_2_7_3_1","first-page":"207","volume-title":"Vasopressin: Cellular and Integrative Functions","author":"ALLISON N.L.","year":"1988"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007297"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50025"},{"key":"e_1_2_7_6_1","first-page":"232","article-title":"Systemic and regional hemodynamic and biological effects of a new \u03ba\u2010opioid agonist, niravoline, in healthy volunteers","volume":"278","author":"BELLISANT E.","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90287-2"},{"key":"e_1_2_7_8_1","first-page":"194","article-title":"Comparison between two aquaretic drugs (niravoline vs OPC\u201031260) in cirrhotic rats with ascites and water retention","volume":"289","author":"BOSCH\u2010MARCE M.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)90911-5"},{"key":"e_1_2_7_10_1","first-page":"379","volume-title":"Ascites and Renal Dysfunction in Liver Disease. Pathogenesis Diagnosis and Treatment","author":"CL\u00c0RIA J.","year":"1999"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90222-7"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00116-8"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50143"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36375"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000181811"},{"key":"e_1_2_7_16_1","first-page":"S38","article-title":"Mechanisms of action of vasopressin and vasopressin antagonists","volume":"34","author":"JARD S.","year":"1988","journal-title":"Kidney Int."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050215"},{"key":"e_1_2_7_18_1","first-page":"83","article-title":"Long\u2010term aquaretic efficacy of a selective nonpeptide V2\u2010vasopressin receptor antagonist, SR121463, in cirrhotic rats","volume":"295","author":"JIM\u00c9NEZ W.","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(02)94708-3"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/329839a0"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.03.083"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2001"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000183112"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7209515"},{"key":"e_1_2_7_25_1","first-page":"427","article-title":"Nonpeptide antagonist for vasopressin receptors\u2010pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist","volume":"449","author":"SERRADEIL\u2010LE GAL C.","year":"1998","journal-title":"Vasopressin Oxytocin"},{"key":"e_1_2_7_26_1","first-page":"585","article-title":"Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine","volume":"220","author":"SLIZGI G.R.","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_27_1","first-page":"301","article-title":"Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo","volume":"282","author":"TAHARA A.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc4501.099313"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50021"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00315-7"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb09058.x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0706375","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0706375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/sj.bjp.0706375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:03:15Z","timestamp":1697112195000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1038\/sj.bjp.0706375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1038\/sj.bjp.0706375"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjp.0706375","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"2009-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}